Application Nr Approved Date Route Status External Links
ANDA202074 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Olanzapine And Fluoxetine Capsules Are Indicated For The Treatment Of: Acute Depressive Episodes In Bipolar I Disorder [see Clinical Studies (14.1) ]. Treatment Resistant Depression (major Depressive Disorder In Patient Who Do Not Respond To 2 Separate Trials Of Different Antidepressants Of Adequate Dose And Duration In The Current Episode) [see Clinical Studies (14.2) ]. Olanzapine And Fluoxetine Capsules Combine Olanzapine, An Atypical Antipsychotic And Fluoxetine, A Selective Serotonin Reuptake Inhibitor, Indicated For Treatment Of: Acute Depressive Episodes Associated With Bipolar I Disorder (1) Treatment Resistant Depression (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments